Remarkably, comparing with luminal and HER2 phenotypes, triple negative breast cancer (TNBC) has abundance of CD44 + /CD24- stem cells, due to their potent self-renewal and differentiation capacities [108, 109]. The gene discussed is CD24; the disease is triple-negative breast carcinoma.